» Articles » PMID: 3089939

Laminar Air Flow Isolation and Decontamination: a Prospective Randomized Study of the Effects of Prophylactic Systemic Antibiotics in Bone Marrow Transplant Patients

Overview
Journal Infection
Date 1986 May 1
PMID 3089939
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

122 patients with hematologic malignancies underwent allogeneic marrow transplantation from HLA-matched sibling donors and received one of two forms of infection prophylaxis while granulocytopenic: 1) decontamination and laminar air flow isolation (LAF, 68 patients), and 2) LAF plus prophylactic systemic antibiotics (LAF + PSA, 54 patients). Patients were evaluated for infection acquisition while in isolation. Septicemia occurred in 11 (16%) of the patients in the LAF group and in three (6%) patients in the LAF + PSA group. Fourteen (21%) of the patients in the LAF group and four (7%) patients in the LAF + PSA group had a major local infection. There was no difference in the incidence and severity of graft-versus-host disease or incidence and duration of fever. The addition of prophylactic intravenous broad-spectrum antibiotics for patients isolated in LAF rooms significantly decreased infection acquisition.

Citing Articles

Fecal Microbiota Transplantation for Treatment of Acute Graft--Host Disease.

Shouval R, Geva M, Nagler A, Youngster I Clin Hematol Int. 2021; 1(1):28-35.

PMID: 34595408 PMC: 8432378. DOI: 10.2991/chi.d.190316.002.


Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure.

Uribe-Herranz M, Klein-Gonzalez N, Rodriguez-Lobato L, Juan M, Fernandez de Larrea C Int J Mol Sci. 2021; 22(3).

PMID: 33498529 PMC: 7864170. DOI: 10.3390/ijms22031026.


Microbiome Anomalies in Allogeneic Hematopoietic Cell Transplantation.

Schwabkey Z, Jenq R Annu Rev Med. 2020; 71:137-148.

PMID: 31986084 PMC: 8353672. DOI: 10.1146/annurev-med-052918-122440.


The gut microbiota and graft-versus-host disease.

Fredricks D J Clin Invest. 2019; 129(5):1808-1817.

PMID: 31042160 PMC: 6486325. DOI: 10.1172/JCI125797.


Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD.

Kohler N, Zeiser R Front Immunol. 2019; 9:3179.

PMID: 30705680 PMC: 6344415. DOI: 10.3389/fimmu.2018.03179.


References
1.
Thomas E, Storb R, Clift R, Fefer A, Johnson F, Neiman P . Bone-marrow transplantation (first of two parts). N Engl J Med. 1975; 292(16):832-43. DOI: 10.1056/NEJM197504172921605. View

2.
Buckner C, Clift R, Sanders J, Meyers J, COUNTS G, Farewell V . Protective environment for marrow transplant recipients: a prospective study. Ann Intern Med. 1978; 89(6):893-901. DOI: 10.7326/0003-4819-89-6-893. View

3.
Petersen F, Clift R, HICKMAN R, Sanders J, Meyers J, Kelleher J . Hickman catheter complications in marrow transplant recipients. JPEN J Parenter Enteral Nutr. 1986; 10(1):58-62. DOI: 10.1177/014860718601000158. View

4.
Deeg H, Storb R, Thomas E, Flournoy N, Kennedy M, Banaji M . Cyclosporine as prophylaxis for graft-versus-host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia. Blood. 1985; 65(6):1325-34. View

5.
Storb R, Deeg H, Thomas E, Appelbaum F, Buckner C, Cheever M . Marrow transplantation for chronic myelocytic leukemia: a controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host disease. Blood. 1985; 66(3):698-702. View